Vendor source
Reviewed 11 May 2026
Completeness Strong (69%)
ChestLink
OxipitChestLink is the first fully autonomous AI medical imaging product with a CE mark. ChestLink identifies CXRs with no abnormality and produces finalized patient reports without any intervention from the radiologist, reducing radiologist workload and enabling them to focus on cases with pathologies.
Supported by 2 papers
Key features
Autonomous healthy patients report generation
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Nov 23, 2023 | Last updated: May 11, 2026